Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device review "consumer-oriented" performance goals under development by FDA.

This article was originally published in The Gray Sheet

Executive Summary

FDA DEVICE REVIEW "CONSUMER-ORIENTED" PERFORMANCE GOALS UNDER DEVELOPMENT at the agency as part of a pilot pro-gram to be proposed under the Government Performance and Results Act of 1993, according to agency staffers. The bill (S 20), which was signed into law on Aug. 3, 1993, calls on the federal government to improve "program effectiveness and public accountability by promoting a new focus on results, service quality, and customer satisfaction."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel